SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-008606
Filing Date
2020-05-29
Accepted
2020-05-29 14:23:46
Documents
14
Period of Report
2020-05-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cort-20200527.htm   iXBRL 8-K 53472
  Complete submission text file 0001628280-20-008606.txt   201198

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20200527.xsd EX-101.SCH 2599
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20200527_cal.xml EX-101.CAL 744
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20200527_def.xml EX-101.DEF 1689
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20200527_lab.xml EX-101.LAB 25488
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20200527_pre.xml EX-101.PRE 13281
7 EXTRACTED XBRL INSTANCE DOCUMENT cort-20200527_htm.xml XML 10997
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 20926708
SIC: 2834 Pharmaceutical Preparations